These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19348930)

  • 41. Hyper-IgE syndrome associated with an IL-4-producing gamma/delta(+) T-cell clone.
    Simon HU; Seger R
    J Allergy Clin Immunol; 2007 Jan; 119(1):246-8. PubMed ID: 17208609
    [No Abstract]   [Full Text] [Related]  

  • 42. Hyper-IgE syndrome.
    Feingold M
    N Engl J Med; 1999 Jul; 341(5):376-7. PubMed ID: 10428669
    [No Abstract]   [Full Text] [Related]  

  • 43. Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohort.
    Alcántara-Montiel JC; Staines-Boone T; López-Herrera G; Espinosa-Rosales F; Espinosa-Padilla SE; Hernández-Rivas R; Santos-Argumedo L
    Clin Genet; 2016 Feb; 89(2):217-21. PubMed ID: 26293184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperimmunoglobulin-E syndrome.
    Mahdi OZ; Mathelier LL; Al-Bardeisi NH
    Saudi Med J; 2002 Apr; 23(4):461-3. PubMed ID: 11953776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusual psoriasiform lesions in a patient with Hyper-IgE syndrome.
    Li XL; Geng SM; Lei XB; Xiao SX; Liu Y; Peng ZH
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):424-6. PubMed ID: 17309489
    [No Abstract]   [Full Text] [Related]  

  • 46. Fournier gangrene associated with hyper IgE syndrome (Job syndrome).
    Hori J; Yamaguchi S; Watanabe M; Osanai H; Hori M
    Int J Urol; 2008 Apr; 15(4):372-3. PubMed ID: 18380833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Boy with Relentless Pruritus: Job's Syndrome.
    Khan K; Wozniak SE; Giannone AL; Abdulmassih ME
    Am J Case Rep; 2016 Feb; 17():104-10. PubMed ID: 26897360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual coexistence of molluscum contagiosum and verruca plana in a hyper-IgE syndrome.
    Lei XB; Geng SM; Zeng WH; Tan SS; Wang JM; Xiao SX
    Int J Dermatol; 2006 Oct; 45(10):1199-201. PubMed ID: 17040440
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyper IgE syndrome: anaphylaxis in a patient carrying the N567D STAT3 mutation.
    Merli P; Novara F; Montagna D; Benzo S; Tanzi M; Turin I; De Amici M; Merli A; Zuffardi O; Marseglia GL
    Pediatr Allergy Immunol; 2014 Aug; 25(5):503-5. PubMed ID: 24628715
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter to the editor: Methisoprinol: a novel addition to hyper IgE arsenal.
    Feily A
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):530-1. PubMed ID: 20017655
    [No Abstract]   [Full Text] [Related]  

  • 51. Lithium: a potential treatment for hyper-IgE syndrome.
    Namazi MR; Handjani F
    Med Hypotheses; 2006; 66(5):1047. PubMed ID: 16455207
    [No Abstract]   [Full Text] [Related]  

  • 52. Rituximab in a patient with Hyper-IgE syndrome.
    Trendelenburg M; Schifferli JA
    Arch Dermatol; 2007 Jun; 143(6):807-8. PubMed ID: 17576959
    [No Abstract]   [Full Text] [Related]  

  • 53. A rare cause of gastrointestinal bleeding in a patient with hyper-IgE syndrome.
    Götzberger M; Schlesinger A; Dauer M; Heldwein W; Jansson A; Renner E; Belohradsky BH
    Gut; 2004 Oct; 53(10):1430, 1436. PubMed ID: 15361489
    [No Abstract]   [Full Text] [Related]  

  • 54. Association between nasal polyposis, Dubowitz syndrome and hyper-IgE syndrome.
    Sarmento KM; Tomita S; Caliman e Gurgel JD
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):711-4. PubMed ID: 18329728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
    Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
    Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An unusual acute myeloid leukemia associated with hyper IgE: another case of AML-M5c?
    Lima M; Orfão A; Coutinho J; Ferreira G; Freitas I; Silvestre F; Justiça B
    Haematologica; 2001 Feb; 86(2):216-7. PubMed ID: 11224498
    [No Abstract]   [Full Text] [Related]  

  • 57. Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab.
    Bard S; Paravisini A; Avilés-Izquierdo JA; Fernandez-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2008 Dec; 144(12):1662-3. PubMed ID: 19075161
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hyper IgE syndrome].
    Kobayashi Y; Taniuchi S
    Ryoikibetsu Shokogun Shirizu; 2000; (32):362-4. PubMed ID: 11212745
    [No Abstract]   [Full Text] [Related]  

  • 59. Nuclear protein IkappaB-zeta inhibits the activity of STAT3.
    Wu Z; Zhang X; Yang J; Wu G; Zhang Y; Yuan Y; Jin C; Chang Z; Wang J; Yang X; He F
    Biochem Biophys Res Commun; 2009 Sep; 387(2):348-52. PubMed ID: 19595668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [STAT3 mutation in a child with hyper-IgE syndrome and incomplete clinical features].
    Szaflarska A; Rutkowska-Zapała M; Pituch-Noworolska A; Siedlar M
    Przegl Lek; 2015; 72(12):787-90. PubMed ID: 27024962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.